FierceBiotech

Abbott snags FDA nod for insertable cardiac monitor that can stay in place for up to 6 years

Many insertable cardiac monitors, known as ICMs or loop recorders, are already able to stay in place under the skin for several years at a time, enabling long-term tracking of irregular heartbeats—but ...
Healio

FDA clears insertable cardiac monitor with long battery life

Please provide your email address to receive an email when new articles are posted on . Abbott announced the FDA cleared its insertable cardiac monitor for diagnosis and evaluation of irregular ...
EurekAlert!

Wearable heart monitor increases diagnoses of common heart rhythm disorder by 50%

London, United Kingdom – 1 September 2024: Screening for atrial fibrillation (AF) using a wearable heart monitor for 2 weeks can identify older adults with this potentially dangerous abnormal heart ...
Nasdaq

Abbott's (ABT) Assert-IQ Cardiac Monitor Receives CE Mark

Abbott Laboratories, Inc. ABT recently announced the receipt of CE Mark in Europe for its Assert-IQ insertable cardiac monitor (ICM). The ICM offers physicians a new option for diagnostic evaluation ...
Healio

Insertable cardiac monitor for atrial fibrillation detection likely cost-effective in US

Please provide your email address to receive an email when new articles are posted on . Insertable cardiac monitoring was estimated to be cost-effective for AF detection in the U.S. This finding was ...
Seeking Alpha

Abbott wins FDA nod for insertable cardiac monitor Assert-IQ

Abbott Laboratories (NYSE:ABT) announced Thursday that the U.S. Food and Drug Administration (FDA) cleared its Assert-IQ insertable cardiac monitor, a device to detect irregular heartbeats. Assert-IQ ...
Nasdaq

Abbott's (ABT) Assert-IQ Cardiac Monitor Receives FDA Approval

Abbott Laboratories, Inc. ABT recently announced the receipt of the FDA approval for its Assert-IQTM insertable cardiac monitor (ICM), giving doctors a new choice for the diagnostic assessment and ...